Earnings Ahead

MRK - Merck

113.37 3.1 2.81

Merck

Merck

About

Profile

Our corporate responsibility approach is aligned with our company’s focus on invention, and underscores our commitment to overcoming the greatest obstacles to health and well-being, developing and rewarding our employees, protecting the environment, and


Headquarters

Kenilworth, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

MRK



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Susan Monarez wins Senate confirmation as CDC director
  • FDA vaccines head, chief medical officer Vinay Prasad departs agency
  • Merck outlines $3B reinvestment initiative and expects 1%–2% revenue growth for 2025 while advancing new product launches
  • EU pharma lobby criticizes potential Trump tariffs on pharmaceuticals
  • Biggest stock movers Tuesday: SOFI, UNH, TLRY, PHG, and more
  • Merck in Charts: KEYTRUDA sales surge 9% Y/Y, GARDASIL dips 54% in Q2
  • Merck plans $3B annual cost cuts as Keytruda faces patent cliff
  • Merck Non-GAAP EPS of $2.13 beats by $0.10, revenue of $15.81B misses by $60M
  • RFK Jr. seeks to 'fix' Vaccine Injury Compensation Program
  • Merck Q2 Earnings Preview: What to expect?
  • Merck declares $0.81 dividend
  • Former biotech exec George Tidmarsh to lead key FDA drug center
  • Bristol Myers fails in late-stage trial for Merck-partnered anemia therapy in blood cancer
  • Trump eyes drug, chip tariffs by month-end
  • Merck to begin late-stage trials for HIV prevention pill
  • Key deals this week: Meta, Boyd Gaming, Merck, Sandstorm Gold, Capgemini and more
  • FDA mulls faster drug reviews in exchange for lower prices in U.S.- Bloomberg
  • Merck Animal Health gets FDA nod for Bravecto Quantum
  • FDA publishes more than 200 rejection letters in a bid to improve transparency
  • Merck's doravirine/islatravir under FDA review for HIV

Earnings History

Date EPS / Forecast Revenue / Forecast
February 3, 2022 1.8 / 1.52 13.52B / 13.14B Beat!
October 28, 2021 1.75 / 1.55 13.15B / 12.32B Beat!
July 29, 2021 1.31 / 1.31 11.4B / 11.08B Beat!
April 29, 2021 1.33 / 1.53 12.08B / 12.61B
February 4, 2021 1.32 / 1.38 12.51B / 12.67B
October 27, 2020 1.74 / 1.44 12.55B / 12.21B Beat!
July 31, 2020 1.37 / 1.06 10.87B / 10.4B Beat!
April 28, 2020 1.5 / 1.34 12.06B / 11.48B Beat!
February 5, 2020 1.16 / 1.15 11.87B / 11.98B
October 29, 2019 1.51 / 1.24 12.4B / 11.64B Beat!
July 30, 2019 1.3 / 1.16 11.76B / 10.96B Beat!
April 30, 2019 1.22 / 1.05 10.82B / 10.47B Beat!
February 1, 2019 1.04 / 1.04 11B / 10.94B Beat!
October 25, 2018 1.19 / 1.14 10.79B / 10.89B
July 27, 2018 1.06 / 1.03 10.47B / 10.28B Beat!
May 1, 2018 1.05 / 1 10.04B / 10.09B
February 2, 2018 0.98 / 0.94 10.43B / 10,494M
October 27, 2017 1.11 / 1.03 10.33B / 10,545M
July 28, 2017 1.01 / 0.87 9.93B / 9,746M Beat!
May 2, 2017 0.88 / 0.83 9.43B / 9,250M Beat!
Date Price Open High Low Vol Change ER
May 26, 2023 111.07 112
113.19
110.65
6.3M -1.1%
May 25, 2023 112.3 113.5
113.5
111.09
6.7M -1.14%
May 24, 2023 113.6 114.11
114.32
112.55
4.5M 0.29%
May 23, 2023 113.27 113.97
114.79
113.05
7.6M -1.07%
May 22, 2023 114.49 115.48
117.08
114.33
5.6M -0.87%
 
May 19, 2023 115.49 114.33
116.24
114.1
7.6M 1.31%
May 18, 2023 114 114.14
115.07
113.33
6.4M -0.66%
May 17, 2023 114.76 116.37
116.65
113.48
7.2M -1.14%
May 16, 2023 116.08 115.88
116.76
115.29
4.3M -0.25%
May 15, 2023 116.37 117.14
117.74
115.49
5.7M -0.66%
May 12, 2023 117.14 118
118.55
116.69
5.2M -0.35%
May 11, 2023 117.55 117.58
117.79
116.38
5.6M -0.3%
May 10, 2023 117.9 117.41
118.17
116.42
5.6M 0.40%
May 9, 2023 117.43 118.25
118.63
117.34
4.9M -0.8%
May 8, 2023 118.38 117.08
118.44
116.44
5.2M 0.59%
May 5, 2023 117.68 117.38
117.89
116.56
4.5M 0.26%
May 4, 2023 117.37 118
118
116.49
6.5M -0.72%
May 3, 2023 118.22 118.35
119.65
117.93
6.7M 0.28%
May 2, 2023 117.89 116.67
118.39
115.81
8.2M 1.33%
May 1, 2023 116.34 115.8
116.6
115.27
5.2M 0.75%
Apr 28, 2023 115.47 114.36
115.53
113.46
8.1M 0.27%
Apr 27, 2023 115.16 114.6
115.36
110.65
10.0M 1.53%
Apr 26, 2023 113.43 115.2
115.2
112.72
6.6M -2.66%
Apr 25, 2023 116.53 116.21
116.86
115.91
5.7M 0.51%
Apr 24, 2023 115.94 115.64
116.28
114.77
4.3M 0.49%
Apr 21, 2023 115.37 114.87
115.65
114.59
6.6M 1.05%
Apr 20, 2023 114.17 114.18
114.52
113
4.7M 0.04%
Apr 19, 2023 114.13 114.49
115.39
114.01
4.7M -0.61%
Apr 18, 2023 114.83 114.48
115.12
113.73
5.5M -0.16%
Apr 17, 2023 115.01 115.69
116.44
114.2
6.6M -0.26%
Apr 14, 2023 115.31 115.74
116.17
114.66
5.0M -0.23%
Apr 13, 2023 115.58 114.97
115.82
113.65
7.3M 1.61%
Apr 12, 2023 113.75 112.25
114.31
111.88
6.1M 1.12%
Apr 11, 2023 112.49 112.72
113.31
112.32
5.6M -0.11%
Apr 10, 2023 112.61 112.96
113.09
111.17
6.4M 0.25%
Apr 6, 2023 112.33 113
114.17
111.64
6.9M 0.38%
Apr 5, 2023 111.91 109.91
112.34
109.58
8.0M 2.83%
Apr 4, 2023 108.83 108.7
109.34
108.15
6.1M -0.04%
Apr 3, 2023 108.87 105.95
109.48
105.57
7.0M 2.33%
Mar 31, 2023 106.39 106.23
106.53
105.52
7.2M 0.44%
Mar 30, 2023 105.92 105.12
106.2
104.54
5.0M 0.95%
Mar 29, 2023 104.92 105.62
105.87
104.53
6.3M -0.58%
Mar 28, 2023 105.53 106.61
107.03
105.43
6.7M -1.31%
Mar 27, 2023 106.93 106.08
107.61
105.99
7.6M 2.03%
Mar 24, 2023 104.8 104.09
105.01
102.44
6.7M 0.55%
Mar 23, 2023 104.23 104.1
104.63
103.46
6.8M -0.16%
Mar 22, 2023 104.4 105.47
106
104.39
5.7M -1.08%
Mar 21, 2023 105.54 106
106.43
104.76
11.6M -0.29%
Mar 20, 2023 105.85 104.82
106.91
104.82
12.9M 1.68%
Mar 17, 2023 104.1 107.15
107.31
103.49
26.4M -3.02%
Mar 16, 2023 107.34 106.5
107.71
104.22
9.4M -0.27%
Mar 15, 2023 107.63 106.48
108.03
105.57
10.9M 0.62%
Mar 14, 2023 106.97 105.45
107.13
104.52
9.8M 1.17%
Mar 13, 2023 105.73 104.47
108.84
104.4
10.7M -1.82%
Mar 10, 2023 107.69 107.44
110.72
107.34
9.7M 0.08%
Mar 9, 2023 107.6 109.3
109.9
107.11
5.8M -0.63%
Mar 8, 2023 108.28 110.93
111.28
107.59
8.4M -2.69%
Mar 7, 2023 111.27 111.77
112.18
110.71
13.8M 0.15%
Mar 6, 2023 111.1 107.66
111.24
107.45
17.8M 3.95%
Mar 3, 2023 106.88 107.38
107.39
106.13
6.1M 0%